$JNJ (3%) YTD Loss to $142. As low as $111 in Mar '20

MA (50)=$146

Q1'20 YOY

Rev=$20.7B, up 3%
-Pharma=$11B, up 10%
*Oncology: growth w/ Darzalex
-Med Devices=$6B, down (7%)
*Surgery: Endocutters (-) impact
-Consumer Health=$3.6B, up 11%
*Zarbee's Naturals: + growth

P/L=$5.8B https://t.co/s3B6x7WSWa